2 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow Bronchial Spasm: new trials by email Literature Review of Bronchial Spasm trials Research Report on Bronchial Spasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Epinephrine Inhalation Aerosol USP, a HFA-MDI Study for Assessment of Pharmacokinetics Epinephrine Inhalation Aerosol, HFA, Epinephrine Inhalation Aerosol - Asthma, Bronchospasm | Phase 1 / Phase 2 | Completed | Amphastar Pharmaceuticals, Inc. | 23 | 2010-08-01 | 2017-07-25 |
| A First Time In Human Study To Assess The Compound GSK615915 GSK615915A, Placebo - Bronchospasm | Phase 1 | Completed | GlaxoSmithKline | 46 | 2005-11-23 | 2017-09-29 |
Asthma (1) · Dyspnea (1) · Respiratory Sounds (1)
Bronchial Diseases (2) · Respiratory Tract Diseases (2) · Hypersensitivity (1) · Hypersensitivity, Immediate (1) · Immune System Diseases (1) · Lung Diseases (1) · Lung Diseases, Obstructive (1) · Pathological Conditions, Signs and Symptoms (1) · Respiration Disorders (1) · Respiratory Hypersensitivity (1) · Signs and Symptoms (1) · Signs and Symptoms, Respiratory (1)
Epinephrine (1) · Inhalation (1)
Amphastar Pharmaceuticals, Inc. (1) · GlaxoSmithKline (1)
United Kingdom (1) · United States (1)